FLUOROCHEM Q1 FY27 earnings call.
A source-linked concall view: reported numbers, management language, guidance, commitments and risks that should carry forward.
ConCallIQ research layer
Signal, with the source still visible.
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Revenue
₹1,588 Cr
verified against source
Revenue YoY
24%
reported change
EBITDA
₹428 Cr
latest reported figure
Source
screener in
record provenance
Actual signal trajectory
Where this quarter sits.
Quarter read
What the record says.
GFL delivered a strong Q1 FY27 with consolidated revenue of Rs 1,588 crore (+24% YoY), EBITDA of Rs 428 crore (+24% YoY) at 27% margin, and PAT of Rs 219 crore (+19% YoY) at 14% margin. The fluorochemical segment was exceptional, growing 52% YoY to Rs 1,574 crore driven by R32 refrigerant sales with near-full capacity utilization at 10,000 tons. Fluoropolymers delivered 15% YoY growth supported by new high-value grade approvals in semiconductors, data centers, and green hydrogen applications. Battery materials remain in qualification phase with management guiding to 3-digit revenue in Q4 FY27 and significant ramp-up in FY28. Working capital improved by 43 days to 149 days. The Oman battery project has been relocated to India due to geopolitical delays, though no funding constraints are anticipated. Fluoropolymer approvals expected to be largely in place by FY27 year-end enabling volume ramp-up in H2.
Colored figures show movement against the previous available record.
Guidance to track
- Management maintained the annual growth target for fluoropolymers driven by volume additions from new high-value grades and debottlenecking activities. Most approvals for new products expected in place by FY27 year-end.
- Existing R32 capacity at 10,000 tons is fully utilized. Expansion expected to be commissioned in Q2 FY27 targeting full utilization in calendar year 2027 across domestic and export markets.
- R134A capacity expected to be commissioned by end of FY27 (targeting earlier). Brownfield expansion at existing site with TCO to be imported. Will complete refrigerant bouquet alongside R32, R22, and R125.
- Management confirmed being on track to achieve three-digit revenue in Q4 FY27 with significant ramp-up expected in FY28. LiPF6 in growth phase, PVDF close to qualification completion, LFP cathode materials toward end of FY27.
Risks flagged
- The 216 million dollar Oman battery materials project has been put on hold and relocated to India due to geopolitical delays. The previously approved 1,200 crore funding from a sovereign fund will not be available for the India project, requiring alternative funding arrangements.
- Analyst asked about consumption quota allocation for R32 sales to new players. Management deflected, stating they cannot comment and will follow up separately, indicating uncertainty on how quota formulas apply to new market participants.
- While management stated they do not compete directly with Chinese players in high-value segments, price increases in commodity fluoropolymers have been small and will reflect in subsequent quarters. Margins in commodity grades remain under pressure despite formula-based pricing protections.
- Battery materials qualification and stabilization takes approximately 1.5 years. Full potential from current capex investments will materialize from FY28 onwards. Any further delays in customer qualifications could impact revenue ramp-up timelines.
Key quotes
- We have been also making this commentary from last few quarters that we are trying to move up the value added chain into the fluoropolymer products and hence we do not have much of a competition with Chinese people.
- 3M is now an event of the past now. So in the last two years we have more or less taken the full impact of whatever 3M exit happened... Now coming toAGC that announcement has just come yet. So we have started getting some queries and inquiries from the customers who were using their material.
- We expect to grow further from here on polymers has done well and expected to grow as we had said earlier 17 to 20% annually going forward. Fluorochemical segment has emerged as a very strong contributor to our financial and is expected to contribute meaningfully to our profitability going forward.
Research modules
